The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Mon, 11th Oct 2021 10:59

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cadence Minerals PLC, up 42% at 24.65 pence, 12-month range 11.1p-32.49p. Receives confirmation from its secured bank creditors that they have obtained approval from their credit committees for the proposed terms of a settlement agreement, paving the way for Cadence to vest an initial 20% in the Amapa iron ore project in Brazil. A joint venture between Cadence and Indo Sino Trade Pte Ltd will own 99.9% of DEV Mineracao SA, the owner of the Amapa project. "Today's announcement is a landmark for Amapa, both in terms of certainty for DEV employees, the wider Amapa community and for Cadence shareholders," says Chair Andrew Suckling.

----------

Reneuron Group PLC, up 31% at 123.80p, 12-month 70p-153.78p. The biotechnology company reports positive data that provides "clear pre-clinical proof-of-concept" that its novel exosome drug delivery technology can effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases. "These results are a key milestone for our exosome delivery technology, establishing clear proof of concept in vivo, which more accurately imitates conditions for the targeted delivery of key neurological therapeutics into the human brain," says Chief Executive Olav Hellebo.

----------

Feedback PLC, up 16% at 0.8432p, 12-month range 0.6p-1.57p. The medical imaging software company signs memorandum of understanding with Quest Teleradiology Solutions - a teleradiology organisation with customers across India, the UK and throughout Africa - to develop strategic opportunities for Bleepa, its clinical communications platform, in the "large and growing" Indian healthcare market, the UK and internationally.

----------

Oracle Power PLC, up 15% at 0.385p, 12-month 0.3p-0.75p. The natural resources project developer signs non-exclusive co-operation agreement with PowerChina International Group Ltd to jointly develop a green hydrogen production facility in Pakistan. It is targeting 400 megawatt capacity hydrogen plant, with planned output of around 150,000 kilograms per day.

----------

AIM - LOSERS

----------

ASOS PLC, down 11% at 2,474p, 12-month range 2,300p-5,994.95p. The online fashion retailer posts jump in annual profit, but warns on year ahead and announces departure of chief executive. Adjusted pretax profit for the 2022 financial year expected between around GBP110 million to GBP140 million. This is well below the GBP193.6 million registered for the financial year just ended. ASOS shakes up board to "underpin delivery of the next phase of its global growth strategy". CEO Nick Beighton is stepping down after 12 years with ASOS, including six as CEO, and a search is underway for his replacement.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Jul 2021 15:15

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

Read more
8 Jul 2021 11:38

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

Read more
1 Jul 2021 17:05

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

EXECUTIVE CHANGES: AB Dynamics founder retires; Resolute hires CFO

Read more
9 Jun 2021 17:47

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

TRADING UPDATES: Ted Baker results in line; Gulf Marine raises cash

Read more
20 May 2021 20:23

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

TRADING UPDATES: Amigo wants suspension lift; Young's sinks to loss

Read more
19 Mar 2021 16:43

ReNeuron signs new collaboration agreements

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the signing of new collaboration agreements with a major pharmaceutical company and leading academic institutions in the UK and mainland Europe on Friday.

Read more
19 Mar 2021 11:34

ReNeuron inks commercial collaboration deals for exosome platform

ReNeuron inks commercial collaboration deals for exosome platform

Read more
19 Mar 2021 11:20

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

AIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance

Read more
12 Mar 2021 15:39

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

EXECUTIVE CHANGES: Long-serving Hansard and Northbridge CEOs retire

Read more
27 Jan 2021 13:43

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

IN BRIEF: Schroder UK Public Private Sells Basket Of Seven Assets

Read more
15 Jan 2021 15:29

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

IN BRIEF: ReNeuron Treats First Patient In Extended Retinal Study

Read more
17 Dec 2020 22:00

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

UK TRADING UPDATE SUMMARY: SolGold Encouraged By Drilling At Cascabel

Read more
11 Dec 2020 14:26

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

ReNeuron Conditionally Raises GBP17.5 Million Through Placing

Read more
24 Nov 2020 14:41

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

IN BRIEF: ReNeuron Interim Loss Widens; Raises GBP15 Million

Read more
23 Nov 2020 19:09

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

UK TRADING UPDATE SUMMARY: ReNeuron Plans Fundraise To Support Study

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.